Jon also confirming they have had a number of discussions regarding licensing, takeover and that they are not going to decide until after the FDA meeting next month. (Presumably to get the best value/outcome). Also confirmed our theory that they will be prepared to fund 2 phase 3 without any capital raisings but the likelihood of a transaction occurring from then would be increased. 2 phase 3's is fantastic but there's an opportunity for much more to be occurring and for this drug to be a 10b+ sales monster.
Jon also confirming they have had a number of discussions...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.15 |
Change
-0.940(5.50%) |
Mkt cap ! $2.064B | |||
| Open | High | Low | Value | Volume |
| $15.04 | $16.33 | $14.65 | $25.91M | 1.638M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 125 | $16.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.20 | 1500 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |